cheng

  • Following

    0

  • Followers

    1K

Fame: 7,773
Stocks that are loved will be priced accordingly; Stocks that are hated will tripled tomorrow.
Joined Dec 2017

Comments

cheng replied to comment on SKPRES.
kaput. 2nd qtr with margin below 5% and revenue is down too. No wonder institutions/insiders selling like no tmr. Lol, no pun intended. 2nd half outlook is not good either. The industry is at a low cycle now and performance may remain subdued. Looks like will have to wait for insiders to make a move first before riding it.
1 hour · translate
cheng replied to comment on GENTING.
Probably due to the nature of the company, J. Products/services related to clinical services and diagnostic tools of a biotech company. As for uptake, it's kinda a sure thing :) rationale for that is due to its oral medication instead of the other 2 approved by MHRA - intravenous infusion, expensive and adverse events/side effects.
1 hour · translate
cheng replied to comment on SFPTECH.
AGM next week and hopefully updates from the boss will send it to 3rd floor :)
1 hour · translate
cheng replied to comment on CNERGEN.
yes it is, mil cookie. FY2024 can be used as the baseline; potentially better. Earnings quality will be better than FY2025 too due to the higher margin segment contribution.
1 hour · translate
cheng replied to comment on CNERGEN.
possible but we have no control over the bonus shares outcome, thye. It's easier for us to manage our position - buy in batches and risk mgmt.
1 hour · translate
cheng replied to comment on SFPTECH.
you are welcome, yolo. Its also a form of risk mgmt. allows you to stay in the ride with min to zero risk but at a lower monetary reward.
23 hours · translate
cheng replied to comment on SFPTECH.
its zero cost strategy, yolo. meaning - sell partial to lock in profits and recover your capital. Balance capital divided by balance qty is the avg price. A true zero cost would be to sell the exact qty to recover your capital. The balance qty on hands will be of zero cost. For my case, I didnt want to go to zero cost as balance qty will be too low then :)
23 hours · translate
cheng replied to comment on PENTECH.
dont put much hope on the story of SOC and OCC until its proven
23 hours · translate
cheng replied to comment on GENTING.
the last transacted price for TauRx - TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the “Company” or “Dundee”) announced today that it has sold to a private investor 8,000 of the 1,015,008 shares it holds in TauRX Pharmaceuticals Ltd. (“TauRx”) at a price of US$125 per share for proceeds to the Company of US$1,000,000. The transaction remains subject to TauRx board approval. Following the completion of the transaction Dundee will continue to hold 1,007,008 TauRx shares.
Yesterday · translate
cheng replied to comment on GENTING.
not easy to approve but not rejected yet, Vin. The investment in TauRx is a done deal, and it is now just a matter of when Genting will monetise it / at which price.
Yesterday · translate
Load more